Comprehensive Genomic Profiling is Transforming Precision Medicine

Available On-Demand

On June 4th, 2022, Illumina hosted a networking event at the American Society of Clinical Oncology (ASCO) entitled, "Unlocking Precision Medicine: The Transformational Impact of Comprehensive Genomic Profiling (CGP)." A panel of leading oncologists from academic research institutions and community practices were invited to discuss the utilization of CGP in the clinic with Illumina’s Chief Medical Officer, Dr. Phil Febbo, as a powerful approach to personalize cancer treatment options following diagnosis. Register for this free Inside Precision Medicine webinar and follow the fascinating discussion from the expert panel of clinical oncologists about this burgeoning area of Precision Medicine.

Your details:

First Name *

* Required

Last Name *

* Required

Email *

* Required

Country *

* Required

Organization *

* Required

Area of Interest *

* Required

Job Function *

* Required

I would like to receive additional technical and educational content from the sponsor. *

YesNo * Required

To view GEN’s privacy statement click here.

* Required

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Presenters

David Bartlett, MD

Chair
Allegheny Health Network (AHN) Cancer Institute

Sandip Patel, MD

Associate Professor of Medicine
University of California, San Diego
View Biography

Rachel Sanborn, MD

Medical Oncologist
Earle A. Chiles Research Institute
Providence Cancer Institute

Phil Febbo, MD

Chief Medical Officer
Illumina

Kevin Keegan

Vice President and General Manager, Oncology
Illumina